Variable risks in system development and maintenance and machinery sales
First written in FY2016. 34 of 38 entries say "Materialised", first in FY2017-Q1. Latest entry: 2026-07-29.
No other company in this theme has enough history to compare yet.
- 2026-07-29MaterialisedFinancial results
「Sales amounted to ¥971,091 thousand, down 3.7% year on year, due to the loss of large-scale entrance-examination revision projects and initial implementation projects in education operations from the previous consolidated fiscal year, as well as the impact of ending mock-examination-related operations.」
The loss of large projects from the previous year and the end of mock-examination-related operations caused sales fluctuations in the first-quarter results based on the timing of projects and operations. - FY2026MaterialisedAnnual report
「[Machine Sales] Revenue was ¥77.458 million, down 59.4% year on year, due mainly to the absence of equipment renewals for printers used in medical systems and renewals of medical system infrastructure.」
The absence of equipment renewals and infrastructure upgrades in the medical-related business caused machine sales to decline 59.4% year on year, with the volatility risk in development and machine sales reflected in full-year results. - FY2026-H1MaterialisedAnnual report
「<System Development and Maintenance> Revenue was ¥180.845 million, down 19.5% year on year, due mainly to the absence of development of core clinical laboratory systems in medical-related services. <Machine Sales> Revenue was ¥13.485 million, down 73.3% year on year, due mainly to the absence of equipment renewals for printers used in medical systems.」
The absence of core clinical laboratory system development and equipment renewals for printers used in medical systems caused revenue from system development and maintenance and machine sales to decline 19.5% and 73.3%, respectively, year on year. - FY2025-H1MaterialisedAnnual report
「<System Development and Maintenance> Revenue was ¥224.744 million, up 125.9% year on year, due mainly to WITH-X®-related revenue from development projects, including development of core clinical laboratory systems in medical-related services and development to address regulatory revisions in securities operations. <Machine Sales> Revenue was ¥50.552 million, up 41.5% year on year, due to equipment renewals for printers used in medical systems.」
The occurrence of development projects and equipment renewals caused significant year-on-year fluctuations in revenue from system development and maintenance and machine sales, with the associated volatility risk reflected in results for the interim consolidated accounting period. - FY2024MaterialisedAnnual report
「[System Development and Maintenance] Revenue was ¥268.889 million, up 76.8% year on year, due mainly to the increase in clinical laboratory system development and KIZUNA-X® (Note 3)-related development. [Machine Sales] Revenue was ¥59.155 million, down 26.8% year on year, as deliveries of tablet products for medical systems ran their course.」
System development and maintenance increased 76.8% year on year, while machine sales declined 26.8% as deliveries ran their course, reflecting the impact of project and sales trends on full-year results. - FY2024-Q3MaterialisedAnnual report
「<System Development and Maintenance> Revenue was ¥183.600 million, up 64.8% year on year, due mainly to the increase in clinical laboratory system development and maintenance support projects at subsidiaries.」
Revenue from system development and maintenance was ¥183.600 million, up 64.8% year on year. The increase in clinical laboratory system development and maintenance support projects at subsidiaries was reflected in results. - FY2024-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥99.476 million, up 43.7% year on year, due mainly to development related to KIZUNA-X® in securities operations.」
Revenue from system development and maintenance increased 43.7% year on year to ¥99.476 million, reflecting the impact of KIZUNA-X®-related development projects on results. - FY2024-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥47.444 million, up 43.1% year on year, due mainly to development related to KIZUNA-X in the SAKIX series for securities operations.」
Development related to KIZUNA-X in the SAKIX series resulted in system development and maintenance revenue of ¥47.444 million, up 43.1% year on year. - FY2023MaterialisedAnnual report
「[System development and maintenance] Sales were ¥152.063 million, down 27.3% year on year, due mainly to the absence of website renewal development, My Number-related work in securities operations and spot development projects for e-learning systems. [Machinery sales] Sales were ¥80.790 million, down 21.1% year on year, due mainly to the absence of sales from medical system equipment replacements.」
Development and maintenance revenue fell 27.3% year on year, while machinery sales revenue fell 21.1%, with fluctuations caused by the absence of projects and equipment replacement sales reflected in the full-year results. - FY2023-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥111.414 million, down 25.7% year on year, due mainly to the absence of My Number-related work in securities operations and spot development projects for e-learning systems.」
System development and maintenance revenue was ¥111.414 million, down 25.7% year on year, with fluctuations caused by the absence of My Number-related work and spot e-learning system development projects reflected in the results. - FY2023-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥69.219 million, down 35.7% year on year, due mainly to the absence of My Number-related system development in securities operations and contract work for e-learning system development.」
System development and maintenance revenue was ¥69.219 million, down 35.7% year on year, with fluctuations caused by the absence of contracted e-learning system development work reflected in the results. - FY2023-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥33.152 million, down 51.5% year on year, due mainly to the absence of My Number-related system development in securities operations and system development for Gakken Group companies.」
The absence of development projects, among other factors, resulted in system development and maintenance revenue of ¥33.152 million, down 51.5% year on year, with project fluctuation risk reflected in the results. - FY2022-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥149.909 million, down 23.0% year on year, despite My Number-related system development in securities operations and system development for Gakken Group companies, due mainly to the absence of server replacement development projects in securities operations and application development projects for tablets used with medical systems.」
System development and maintenance revenue was ¥149.909 million, down 23.0% year on year, with fluctuations caused by the absence of server replacement projects in securities operations and application development projects for medical tablets reflected in the results. - FY2022-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥107.574 million, down 5.6% year on year, despite My Number-related system development in securities operations and system development for Gakken Group companies, due mainly to the absence of application development projects for tablets used with medical systems. <Machinery sales> Sales were ¥47.798 million due mainly to sales of medical system equipment; the year-on-year change was not applicable.」
System development and maintenance fell 5.6% year on year due mainly to the absence of application development projects for medical tablets, while machinery sales amounted to ¥47.798 million due to sales of medical system equipment. - FY2022-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥68.422 million, up 40.4% year on year, due mainly to My Number-related system development in securities operations and system development for Gakken Group companies. <Machinery sales> Sales were ¥6.150 million, up 237.4% year on year, due mainly to sales of tablet products for medical systems.」
System development and maintenance and machinery sales fluctuated significantly from the previous period depending on the projects and products sold, with the risk of fluctuations reflected in the results for the current quarter. - FY2021RestatedAnnual report
「The Group's main service is system operations, supplemented by system development and maintenance and machinery sales. System development and maintenance and machinery sales are susceptible to economic conditions, new technologies and useful lives, and performance may fluctuate significantly depending on these factors.」
The risk of fluctuations in system development and maintenance and machinery sales due to economic conditions, new technologies and useful lives continues to be disclosed. - FY2021-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥194.767 million, up 0.9% year on year, due mainly to server replacement development projects in securities operations, despite a decline in application development for tablets used with medical systems.」
The decline in application development for medical tablets coexisted with an increase from server replacement projects in securities operations, with fluctuations in system development and maintenance reflected in the results. - FY2021-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥113.914 million, down 8.1% year on year, despite application development for tablets used with medical systems, due mainly to a decline in server replacement development projects related to the clinical business.」
Despite application development for tablets used with medical systems, system development and maintenance revenue fell 8.1% year on year due mainly to a decline in server replacement development projects for the clinical business. - FY2021-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥48.731 million, down 10.8% year on year, despite a server replacement development project related to the clinical business, due mainly to the absence of development projects for the market surveillance system in securities operations.」
The server replacement project for the clinical business was offset by the absence of development projects for the market surveillance system, among other factors, resulting in a 10.8% year-on-year decline in system development and maintenance revenue. - FY2020MaterialisedAnnual report
「[System development and maintenance] Sales were ¥303.919 million, down 40.4% year on year, due mainly to the absence of system development related to the clinical business and development projects for the securities comprehensive system SENS21.」
The absence of development projects related to the clinical business and SENS21 resulted in a 40.4% year-on-year decline in system development and maintenance revenue, with project fluctuation risk reflected in the full-year results. - FY2020-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥192.944 million, down 50.0% year on year, due mainly to the absence of development projects for the securities comprehensive system SENS21.」
The absence of SENS21 development projects resulted in a 50.0% year-on-year decline in system development and maintenance revenue, with project fluctuation risk reflected in the results. - FY2020-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥124.020 million, down 15.8% year on year, despite system development related to the clinical business, due mainly to the absence of development work for users of the securities comprehensive system SENS21.」
The absence of development work for SENS21 users resulted in a 15.8% year-on-year decline in system development and maintenance revenue. - FY2020-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥54.629 million, down 32.7% year on year, due mainly to the absence of system development for the Gakken Group and development related to the clinical testing business.」
The absence of development projects for the Gakken Group and the clinical testing business resulted in a 32.7% year-on-year decline in system development and maintenance revenue, with project fluctuation risk reflected in the results. - FY2019MaterialisedAnnual report
「[System development and maintenance] Sales were ¥509.508 million, down 1.1% year on year, despite system development related to the clinical business, due mainly to the absence of development projects in financial services and maintenance support projects at subsidiaries. [Machinery sales] Sales were ¥330,000, down 96.6% year on year, due mainly to the absence of license sales to general business corporations.」
The absence of development projects in financial services and other projects resulted in a 1.1% year-on-year decline in system development and maintenance and a 96.6% decline in machinery sales, with fluctuations in projects and sales reflected in the full-year results. - FY2019-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥385.862 million, down 0.3% year on year, despite system development related to the clinical business and development of the Watch21 market surveillance system, due mainly to the absence of development projects in financial services and maintenance support projects at subsidiaries. <Machinery sales> Sales were ¥180,000, down 96.4% year on year, due mainly to the absence of license sales to general business corporations.」
System development and maintenance fell 0.3% year on year, while machinery sales fell 96.4%, with business fluctuations caused by the absence of projects and license sales reflected in the results. - FY2019-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥147.210 million, down 43.7% year on year, despite system development for the Gakken Group, due mainly to the absence of development projects in financial services and maintenance support projects at subsidiaries. <Machinery sales> Sales were nil, down 100.0% year on year, due mainly to the absence of license sales to general business corporations.」
The absence of development projects in financial services and maintenance support projects at subsidiaries resulted in a 43.7% year-on-year decline in system development and maintenance and a 100.0% decline in machinery sales. - FY2019-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥81.125 million, down 14.9% year on year, despite system development for the My Number management system and the Gakken Group, due mainly to the absence of customer system renewal projects and maintenance support projects at subsidiaries. <Machinery sales> Sales were nil, down 100.0% year on year, due to the absence of equipment sales to securities companies.」
System development and maintenance fell 14.9% year on year, while machinery sales fell 100.0%, with fluctuations caused by the absence of projects and equipment sales reflected in the results. - FY2018RestatedAnnual report
「System development and maintenance and machinery sales are susceptible to economic conditions, new technologies and useful lives, and performance may fluctuate significantly depending on these factors.」
The risk of fluctuations in system development and maintenance and machinery sales due to economic conditions, new technologies and useful lives is disclosed again with the same content. - FY2018-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥386.889 million, up 52.2% year on year, due mainly to development work for the introduction of the securities comprehensive system SENS21 by new users and system development for general business corporations. <Machinery sales> Sales were ¥4.957 million, up 28.0% year on year, due mainly to license sales to general business corporations.」
Revenue from system development and maintenance and machinery sales fluctuated from the previous period, with performance fluctuations by business reflected in the third-quarter results. - FY2018-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥261.319 million, up 60.2% year on year, due mainly to development work for the introduction of the securities comprehensive system SENS21 by new users. <Machinery sales> Sales were ¥4.060 million, up 25.5% year on year, due mainly to license sales to general business corporations.」
Revenue from system development and maintenance and machinery sales fluctuated from the previous period, with performance fluctuations by business reflected in the results. - FY2018-Q1MaterialisedAnnual report
「<System development and maintenance> Sales were ¥95.380 million, up 7.5% year on year, due mainly to development work for the introduction of the securities comprehensive system SENS21 by new users. <Machinery sales> Sales were ¥572,000, down 55.6% year on year, due mainly to the absence of customer equipment replacement projects.」
Machinery sales fell 55.6% year on year due to the absence of customer equipment replacement projects, with the risk of fluctuations in development, maintenance and machinery sales reflected in the results. - FY2017RestatedAnnual report
「System development and maintenance and machinery sales are susceptible to economic conditions, new technologies and useful lives, and performance may fluctuate significantly depending on these factors.」
The risk of performance fluctuations in system development and maintenance and machinery sales is disclosed again, together with the same factors. - FY2017-Q3MaterialisedAnnual report
「<System development and maintenance> Sales were ¥254.240 million, up 15.6% year on year, due mainly to customer system renewal projects and system development for general business corporations. <Machinery sales> Sales were ¥3.873 million, down 89.3% year on year, due mainly to the absence of customer equipment replacement projects.」
System development and maintenance increased, while machinery sales fell 89.3% year on year due mainly to the absence of customer equipment replacement projects, with fluctuations in the business reflected in the results. - FY2017-Q2MaterialisedAnnual report
「<System development and maintenance> Sales were ¥163.148 million, down 0.7% year on year, despite an increase from system development for general business corporations, due mainly to the absence of development work associated with customer equipment replacement projects. <Machinery sales> Sales were ¥3.234 million, down 53.9% year on year, due mainly to the absence of customer equipment replacement projects.」
The absence of development work associated with customer equipment replacement projects and the decline in machinery sales are reflected in the results as fluctuations in system development and maintenance and machinery sales. - FY2017-Q1MaterialisedAnnual report
「<Machinery sales> Sales were ¥1.289 million, down 79.4% year on year, due mainly to the absence of customer equipment replacement projects.」
Machinery sales fell 79.4% year on year due to the absence of customer equipment replacement projects, with the risk of fluctuations reflected in the results. - FY2016First statedAnnual report
「System development and maintenance and machinery sales are susceptible to economic conditions, new technologies and useful lives, and performance may fluctuate significantly depending on these factors.」
While aiming to expand its business based on system operations, the Group states that fluctuations in revenue caused by increases or decreases in development and maintenance work are difficult to eliminate.